Cited by 47Tryptophan and brain disordersImmune Response and InflammationImmune cells in cancer

Tryptophan Metabolism Along the Kynurenine Pathway Downstream of Toll‐like Receptor Stimulation in Peripheral Monocytes

Open access
Orhan, F., Bhat, M., Sandberg, K., Ståhl, S., Piehl, F., Karolinska Schizophrenia Project (KaSP) consortium, Svensson, C., Erhardt, S. +1 more·2016·Scandinavian Journal of Immunology

Abstract

Tryptophan degradation along the kynurenine pathway is of central importance for the immune function. Toll‐like receptors ( TLR s), representing the first line of immune defence against pathogens, are expressed in various cell types. The most abundant expression is found on monocytes, macrophages and dendritic cells. The aim of this study was to investigate whether stimulation with different TLR ligands induces the kynurenine pathway in human peripheral monocytes. Cell supernatants were analysed using a liquid chromatography/mass spectrometry to measure kynurenine, kynurenic acid ( KYNA ), quinolinic acid ( QUIN ) and tryptophan. Stimulation of TLR ‐2, TLR ‐3, TLR ‐4, TLR ‐7/8 and TLR ‐9 was found to induce the production of kynurenine, but only stimulation of TLR ‐3 increased levels of further downstream metabolites, such as KYNA and QUIN . Stimulation of TLR ‐1, TLR ‐5 and TLR ‐6 did not induce the kynurenine pathway. Taken together, this study provides novel evidence demonstrating that TLR activation induces a pattern of downstream tryptophan degradation along the kynurenine pathway in monocytes. The results of this study may implicate that TLR s can be used as new drug targets for the regulation of aberrant tryptophan metabolism along this pathway, a potential therapeutic strategy that may be of importance in several disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/sji.12479

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Fujigaki S, Saito K, Sekikawa K et al. Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-- gamma-independent mechanism. Eur J Immunol 2001;31:2313-18.
  2. Erhardt S, Blennow K, Nordin C, Skogh E, Lindstr€ om LH, Engberg G. Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 2001;313:96-8.

Cited by

Sorted by citations

Authors
Orhan, F., Bhat, M., Sandberg, K., Ståhl, S., Piehl, F., Karolinska Schizophrenia Project (KaSP) consortium, Svensson, C., Erhardt, S., & Schwieler, L.
Affiliations
  • Karolinska Institutet (SE)
  • Protein Biomarkers, Personalized Healthcare & Biomarker Laboratories Innovative Medicines Gothenburg Sweden
  • Uppsala University (SE)
Corresponding author
Schwieler, L.
Venue
Scandinavian Journal of Immunology
Publisher
Wiley
Published
2016-10-26
Volume
84
Issue
5
Pages
262-271
ISSN
  • 0300-9475 (ISSN-L)
  • 1365-3083
OpenAlex
W2511451630
Cited by
47
References
59
Citations by year
2026: 4 · 2025: 6 · 2024: 5 · 2023: 11 · 2022: 5 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 3
FWCI
1.00
Type
journal article
Language
en
Open access
Locations
  • Scandinavian Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Medicinska Forskningsrådet (2009‐7053, 2013‐2838)
  • Hjärnfonden
  • Svenska Läkaresällskapet
  • Torsten Söderbergs Stiftelse
  • Karolinska Institutet
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
tryptophan metabolism, kynurenine pathway, Toll-like receptors, peripheral blood monocytes, TLR3, kynurenic acid, quinolinic acid, TLR ligands, tryptophan degradation, therapeutic target
MeSH terms
Flagellin, Gene Expression Regulation, Humans, Hydrolysis, Imidazoles, Kynurenic Acid, Kynurenine, Lipopolysaccharides, Listeria monocytogenes, Monocytes, Poly I-C, Tryptophan, Signal Transduction, Quinolinic Acid, Protein Isoforms, Toll-Like Receptors, Lipopeptides, Primary Cell Culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review